How to Prevent Rubella Epidemics and Congenital Rubella Syndrome: Lessons From 42 Years of Longitudinal Epidemiology in Osaka Prefecture, Japan (1982–2023) - Top-Institutions - MDSpire

How to Prevent Rubella Epidemics and Congenital Rubella Syndrome: Lessons From 42 Years of Longitudinal Epidemiology in Osaka Prefecture, Japan (1982–2023)

  • By

  • Daiki Kanbayashi

  • Takako Kurata

  • Yuko Kaida

  • Tatsuya Miyoshi

  • Fumika Okayama

  • Tetsuo Kase

  • Jun Komano

  • Kazuo Takahashi

  • Kazuyoshi Ikuta

  • Kazushi Motomura

  • August 14, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine-Preventable Diseases

  • #2

    World Health Organization (WHO) Headquarters
    World Health Organization (WHO) Headquarters

    Geneva, Switzerland

    Key Differentiators

    • Global Health
    • Infectious Disease Control
    • Immunization Programs

  • #3

    National Institute of Infectious Diseases (NIID), Japan
    National Institute of Infectious Diseases (NIID), Japan

    Tokyo, Japan

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #4

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Global Health
    • Vaccine-Preventable Diseases

  • #5

    London School of Hygiene & Tropical Medicine (LSHTM)
    London School of Hygiene & Tropical Medicine (LSHTM)

    London, United Kingdom

    Key Differentiators

    • Infectious Disease Epidemiology
    • Vaccine Research
    • Global Health

Original Source(s)

How to Prevent Rubella Epidemics and Congenital Rubella Syndrome: Lessons From 42 Years of Longitudinal Epidemiology in Osaka Prefecture, Japan (1982–2023)

  • by Daiki Kanbayashi, Takako Kurata, Yuko Kaida, Tatsuya Miyoshi, Fumika Okayama, Tetsuo Kase, Jun Komano, Kazuo Takahashi, Kazuyoshi Ikuta, Kazushi Motomura

  • August 14, 2024

Related Content

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection

Sustaining herd immunity against measles: Insights from a serological cohort study in an outbreak-free population

Cervical Cancer Trends Differ by Age

Recent declines among women younger than 35 years contrasted with rising long-term incidence among women aged 35 to 49 years in Puerto Rico